DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹6,391 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹5,079 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹6,391 Cr |
| Mar2024 | ₹5,639 Cr |
| Mar2023 | ₹5,398 Cr |
| Mar2022 | ₹5,079 Cr |
| Mar2021 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,391 Cr | 13.34 | |
| Mar2024 | ₹5,639 Cr | 4.46 | |
| Mar2023 | ₹5,398 Cr | 6.29 | |
| Mar2022 | ₹5,079 Cr | 23.62 | |
| Mar2021 | ₹4,108 Cr | - | |
Compare Total Expenditure of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹175,446.4 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,428.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,603.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹111,604.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,775.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹98,317.8 Cr | 0.9% | -1.2% | 0.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.8% |
-2.3% |
1.5% |
| SENSEX | 3.7% |
2.2% |
-7.2% |
You may also like the below Video Courses